Second Circuit Finds “Product Hopping” By a Pharmaceutical Company to Violate Antitrust Laws
Client Memorandum

Created date


In New York v. Actavis PLC, No. 14-4624 (2nd Cir. May 22, 2015), the United States Court of Appeals for the Second Circuit became the first appellate court to address a pharmaceutical industry practice known as “product hopping.”